Answers are grounded in this paper and cite their sources.
This systematic review and meta-analysis evaluated the association between reminiscence therapy and quality of life (QoL) in older adults, with particular attention to depression-related populations. Six databases were searched for randomised controlled trials published from January 2018 to March 2026 involving adults aged ≥60 years and reporting validated QoL outcomes. Risk of bias was assessed using Cochrane RoB 2. Standardised mean differences (SMDs) were pooled using a random-effects model with restricted maximum-likelihood estimation and Hartung-Knapp adjustment. Nine studies involving 798 participants were included. Reminiscence therapy was associated with improved QoL (SMD = 1.32, 95% confidence interval: 0.44-2.19, p = 0.008), with substantial heterogeneity (I² = 92.9%). Effects were larger for individual-format than group-format interventions (SMDs: 1.60 versus 0.34; p for subgroup difference = 0.012) and in hospital than non-hospital settings (SMDs: 1.81 versus 0.39; p for subgroup difference = 0.002). Funnel plot asymmetry suggested possible small-study effects. These findings support structured, person-centred use of reminiscence therapy in psychogerontological nursing, although substantial heterogeneity and possible small-study effects warrant cautious interpretation. Larger, culturally diverse trials with longer follow-up are needed.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: